D. E. Shaw & Co., Inc. - INTERSECT ENT INC ownership

INTERSECT ENT INC's ticker is XENT and the CUSIP is 46071F103. A total of 132 filers reported holding INTERSECT ENT INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of INTERSECT ENT INC
ValueSharesWeighting
Q1 2022$1,389,000
-47.4%
49,605
-48.7%
0.00%
-50.0%
Q4 2021$2,643,000
-43.0%
96,764
-43.2%
0.00%
-50.0%
Q3 2021$4,638,000
-15.5%
170,504
-46.9%
0.00%
-20.0%
Q2 2021$5,492,000
-24.9%
321,374
-8.2%
0.01%
-28.6%
Q1 2021$7,311,000
-28.4%
350,140
-21.5%
0.01%
-22.2%
Q4 2020$10,212,000
+31.3%
445,933
-6.5%
0.01%
+12.5%
Q3 2020$7,776,000
-2.4%
476,777
-19.0%
0.01%
-11.1%
Q2 2020$7,966,000
+289.5%
588,330
+240.9%
0.01%
+200.0%
Q1 2020$2,045,000
-82.2%
172,569
-62.5%
0.00%
-76.9%
Q4 2019$11,458,000
+182.8%
460,132
+93.2%
0.01%
+160.0%
Q3 2019$4,052,000
+28.4%
238,215
+71.9%
0.01%
+25.0%
Q2 2019$3,155,000
-49.6%
138,609
-28.8%
0.00%
-50.0%
Q1 2019$6,260,000
+70.6%
194,699
+49.5%
0.01%
+60.0%
Q4 2018$3,670,000
+11.3%
130,226
+13.5%
0.01%
+25.0%
Q3 2018$3,298,000
+6.3%
114,711
+38.5%
0.00%0.0%
Q2 2018$3,102,000
+162.7%
82,823
+175.5%
0.00%
+100.0%
Q1 2018$1,181,000
-61.0%
30,060
-67.9%
0.00%
-50.0%
Q4 2017$3,030,000
-29.3%
93,511
-32.0%
0.00%
-42.9%
Q3 2017$4,283,000
+22.4%
137,480
+9.8%
0.01%
+16.7%
Q2 2017$3,500,000
+404.3%
125,237
+209.4%
0.01%
+500.0%
Q1 2017$694,000
+74.8%
40,480
+23.4%
0.00%0.0%
Q4 2016$397,000
-47.6%
32,817
-31.3%
0.00%0.0%
Q3 2016$757,000
+90.7%
47,760
+128.6%
0.00%0.0%
Q1 2016$397,000
-86.4%
20,894
-83.9%
0.00%
-75.0%
Q4 2015$2,920,000
-32.1%
129,787
-29.4%
0.00%
-33.3%
Q3 2015$4,300,000
+14.0%
183,742
+39.4%
0.01%0.0%
Q2 2015$3,773,000
+177.2%
131,802
+150.2%
0.01%
+200.0%
Q1 2015$1,361,000
+140.5%
52,674
+72.6%
0.00%
+100.0%
Q4 2014$566,000
+25.5%
30,512
+4.9%
0.00%0.0%
Q3 2014$451,00029,0860.00%
Other shareholders

There were no reported owners of INTERSECT ENT INC in Q1 2022.

NameSharesValueWeighting ↓
View complete list of INTERSECT ENT INC shareholders